For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sarepta Therapeutics Inc (NASDAQ: SRPT) closed the day trading at $128.65 up 2.64% from the previous closing price of $125.34. In other words, the price has increased by $2.64 from its previous closing price. On the day, 1.36 million shares were traded. SRPT stock price reached its highest trading level at $128.9 during the session, while it also had its lowest trading level at $125.13.
Ratios:
For a better understanding of SRPT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.90. In the meantime, Its Debt-to-Equity ratio is 1.27 whereas as Long-Term Debt/Eq ratio is at 1.19.
On June 26, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $172 to $176.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $157.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $157 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 25 ’24 when Brown Ryan Edward sold 38,957 shares for $161.61 per share. The transaction valued at 6,296,029 led to the insider holds 17,129 shares of the business.
Arif Bilal sold 3,898 shares of SRPT for $636,271 on Jun 25 ’24. The Chief Tech Ops Officer now owns 17,363 shares after completing the transaction at $163.23 per share. On Jun 24 ’24, another insider, Arif Bilal, who serves as the Chief Tech Ops Officer of the company, sold 7,859 shares for $163.08 each. As a result, the insider received 1,281,621 and left with 21,261 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 12268874752 and an Enterprise Value of 12195448832. As of this moment, Sarepta’s Price-to-Earnings (P/E) ratio for their current fiscal year is 318.05, and their Forward P/E ratio for the next fiscal year is 10.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.15 while its Price-to-Book (P/B) ratio in mrq is 11.38. Its current Enterprise Value per Revenue stands at 8.103 whereas that against EBITDA is 156.855.
Stock Price History:
Over the past 52 weeks, SRPT has reached a high of $173.25, while it has fallen to a 52-week low of $55.25. The 50-Day Moving Average of the stock is -8.49%, while the 200-Day Moving Average is calculated to be 7.39%.
Shares Statistics:
Over the past 3-months, SRPT traded about 1.91M shares per day on average, while over the past 10 days, SRPT traded about 1606350 shares per day. A total of 93.73M shares are outstanding, with a floating share count of 89.53M. Insiders hold about 6.16% of the company’s shares, while institutions hold 87.23% stake in the company. Shares short for SRPT as of 1721001600 were 7332218 with a Short Ratio of 3.51, compared to 1718323200 on 9459307. Therefore, it implies a Short% of Shares Outstanding of 7332218 and a Short% of Float of 8.1099994.
